Technical Articles
Cancer Therapy
VEGF165 Protein: A Core Regulator of Angiogenesis and a Therapeutic Target in Cancer Treatment
In 1989, researchers collectively named the substance that promotes vascular endothelial cell permeability as vascular endothelial growth factor. The initial functions of VEGF primarily included promoting the proliferation of vascular endothelial cells, angiogenesis, and increasing vascular permeability.
View details
- Cancer
- VEGF165 Protein
- Cancer Therapy
- Cell Proliferation
Research on BCL-xL/VHL PROTAC Degraders Based on TR-FRET Technology in Antitumor Therapy
BCL-xL is an important anti-apoptotic protein in the BCL-2 family, overexpressed in various cancer cells, and is a well-established therapeutic target for anti-tumor effects.
View details
- Cancer
- BCL-xL/VHL
- Cancer Therapy
- TR-FRET Technology
Biomarkers for predicting the efficacy of immune checkpoint inhibitors
Immune checkpoint blockade therapy, represented by PD-1/PD-L1 inhibitors, is a major breakthrough in the field of cancer treatment.
View details
- Cancer
- PD1/PD-L1
- Immune checkpoint inhibitor
- Cancer therapy
PE-Labeled GUCY2C Fc&Avi Tag: Illuminating a Promising New Target in Cancer Immunotherapy
This article will provide a comprehensive analysis of the PE-Labeled GUCY2C Fc&Avi Tag protein—a high-end multifunctional recombinant protein tool.
View details
- Cancer
- PE-Labeled GUCY2C Fc & Avi Tag
- Cancer Therapy
- Immunotherapy
- 1















